BridgeMD
New treatment option for Systemic Lupus Erythematosus of Childhood (Disorder)
Official title Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
ClinicalTrials.gov ID: NCT06232304
What this study is testing
- What it's testing
- This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSLE when integrated into medical care. This TEACH program aims to teach participants skills in order to cope with fatigue, pain, and depressive symptoms--symptoms that commonly affect adolescents and young adults with lupus.
- Time commitment: about 1 year
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 22
You may be able to join if
- 1) be diagnosed with cSLE, meeting the revised American College of Rheumatology Classification Criteria for SLE by age 18 years
- 2) be between the ages of 12 and 22 years
- 3) in recognition of the heterogeneity of cSLE symptoms, have elevations in fatigue (i.e., T scores ≥60; or at least moderate symptoms, on the PROMIS...
- 4) have English language proficiency (their primary caregiver can have English or Spanish language proficiency for the child to enroll)
- 5) those under age 18 years (US), or 16 years (Canada) must have a consenting caregiver
You likely can't join if
- 1) other chronic medical conditions (e.g., juvenile arthritis)
- 2) a documented developmental delay, severe cognitive impairment, or thought disorder
- 3) an untreated major psychiatric illness (e.g., bipolar disorder, psychosis, severe depression (PHQ9 score ≥21, BDI/CDI II \> 90) or active suicidal...
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
- New Orleans, Louisiana, United States
- Grand Rapids, Michigan, United States
- The Bronx, New York, United States
- Cincinnati, Ohio, United States
- Seattle, Washington, United States
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 1 year per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 22 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States; New Orleans, Louisiana, United States; Grand Rapids, Michigan, United States; The Bronx, New York, United States; Cincinnati, Ohio, United States; Seattle, Washington, United States and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.